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CONCLUSION Elevated MSS in MD is likely to be a consequence of the onset of MD and not 
migraine per se.      
OBJECTIVES Pathologies of the vestibular system influence motion sickness susceptibility 
(MSS). Bilateral vestibular deficits lower MSS, vestibular neuritis or benign paroxysmal 
positional vertigo have little overall effect, whereas vestibular migraine elevates MSS. However, 
less is known about MSS in Meniere’s disease (MD), a condition in which many patients 
experience vestibular loss and migraine symptoms.  
METHODS We conducted an online survey that posed diagnostic and disease questions before 
addressing frequency of headaches, migraines, visual display dizziness (VDD), syncope, social 
life and work impact of dizziness (SWID4) and motion sickness susceptibility (MSSQ). The two 
groups were: diagnosed MD individuals with hearing loss (n=751) and non-MD individuals in 
the control group (n=400).  
RESULTS The MD group showed significantly elevated MSS, more headache and migraine, 
increased VDD, higher SWID4 scores, and increased syncope. MSS was higher in MD than 
controls only after the development of MD but not before, nor in childhood. Although elevated 
in MD compared with controls, MSS was lower than migraine patients from past data. 
Multivariate analysis revealed VDD, SWID4 and MSS in adulthood as the strongest predictors of 
MD, but not headache nor migraine.  
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Motion sickness is commonly provoked by vehicular motion or visual displays which cause 
sensory conflict [1]. In susceptible individuals, these provocative stimuli elicit nausea and 
vomiting and other symptoms including headache, sweating, pallor, increased salivation and 
dizziness. Many of these features of motion sickness resemble symptoms of acute vestibular 
disease.  The relationship of motion sickness to vestibular disease might be described 
respectively as the ‘healthy person in a sick environment versus sick person in a healthy 
environment’. 
Certain groups of patients with vestibular pathologies have reduced or elevated risk for motion 
sickness.  Patients with vestibular migraine (VM) have greatly elevated susceptibility as do 
those with chronic migraine [2,3].  Patients with vestibular neuritis (VN) or benign paroxysmal 
positional vertigo (BPPV) appear to have little overall difference in susceptibility compared to 
controls [3,4].  But within this broad picture many individuals up- or down-regulate their 
sensitivity to motion in response to their vestibular disease [3,4]. Unilateral vestibular loss 
(UVL) decreases susceptibility but to a lesser extent than BVL [4].  It should be noted that these 
were compensated UVL patients [4], i.e. who had adapted to sensory conflict caused by the loss 
of vestibular function on one side, since in the acute phase the usual observation is that UVL 
patients may be more sensitive to motion. Individuals who have complete bilateral loss of 
labyrinthine (vestibular apparatus) function appear to be largely immune to motion sickness 
provoked by physical motion [3] but may have some susceptibility to visually induced motion 
sickness [5].   
However, fewer systematic data are available concerning motion sickness susceptibility in 
Meniere’s disease (MD).  A telephone survey of patients with MD suggested that they had 
elevated motion sickness susceptibility compared to controls but not as elevated as patients 
with vestibular migraine [6].  Here, we aimed to increase our understanding by screening a 
large population of Meniere’s disease patients and healthy controls with an online version of a 
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validated motion sickness susceptibility questionnaire (MSSQ) [7,8]. In addition, we 
investigated possible co-factors which included prevalence of visual display dizziness (VDD), 
migraine, and syncope. Finally, we asked participants to complete the social life and work 
impact of dizziness questionnaire [9] (SWID4).   
 
Material and Methods 
Participants 
We conducted two anonymous online surveys available through the Meniere’s Society’s website 
(UK based charity); one version was customised for MD participants and another for Control 
participants. All participants were provided with briefing information as to the purpose of the 
survey, and had to indicate consent by clicking the consent agreement button without which 
they could not proceed to the survey. Participants were free to withdraw at any time. Ethical 
approval was provided by the relevant ethics committees of Imperial College and University of 
Westminster.  
Survey Questionnaire 
The survey comprised the following items:  age and gender demographics; questions concerning 
Meniere’s diagnosis, disease duration, vertigo attacks; hearing loss; medication(s); SWID4; VDD; 
syncope; headache frequency, migraine, MSSQ.  These are given in more detail below.   
Meniere’s disease items included: diagnosis (unilateral versus bilateral), disease duration 
(years), hearing loss (yes/no), number of Meniere’s related vertigo episodes >20 minutes in the 
previous six and previous one month as defined by the AAO-HNS [10], medication(s) (yes/no, 
medication details).  The impact of dizziness on social life and work was evaluated by the 
SWID4, a set of four social, travel, family and work related questions (single items and total 
score), which has been validated in patient and control samples [9].  Visual Display Dizziness 
(VDD) asked whether dizziness experienced when using visual interfaces impeded their use 
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(smart phones, computers, tablets, etc). An item concerning susceptibility to vasovagal syncope 
and facilitating factors, circumstances and symptoms was derived from Bosser et al [11].  Other 
questions concerned frequency of headaches (ranked never, rarely, sometimes, often) and 
migraine (six items, throbbing, one or both sides of head, photophobia, phonophobia, nausea, 
clinical diagnosis confirmation, total score=summed items) [12]. Motion Sickness Susceptibility 
Questionnaire (MSSQ) was divided into three parts for Meniere’s patients or two parts for 
Controls. Part A (MSA) referred to the experience of motion sickness in childhood; Part B (MSB) 
to the last 10 years of adulthood for controls or the 10 years before disease onset in Meniere’s 
patients; Part C (MSC) after the onset of Meniere’s disease. In the analysis, Part B scores from 
controls were compared to Part C scores from Meniere’s patients. Scores for each part can range 
from 0-27 maximum possible score, higher scores indicating greater level of susceptibility to 
motion sickness. The MSSQ is a validated questionnaire that reliably predicts motion sickness 
tolerance from testing in laboratory settings and from vehicular motion [7,8,13]. 
Statistics 
Chi-square, Mann-Whitney, ANOVA and specific comparisons were used to explore differences 
between groups. Multivariate techniques including logistic regression, multiple linear 
regression and factor analysis were used to explore the best predictor variables for group 
classification, dependent variable magnitude and latent variables, respectively.    
 
Results 
Eight hundred and ninety six participants completed the MD version of the survey.  However, 
145 participants declared no hearing loss and were excluded. There were 751 participants in 
the MD group (mean+SD: age 49.8+12.8 years; M/F ratio .15/.85) and n=400 non-MD Control 
group (age 45.0+11.2 years; M/F ratio .17/.82).  There was no significant gender bias between 
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MD and Control groups (p=0.619).  In the Control group, 72 participants (18%) reported a 
hearing loss.    
------------------------------------------- 
Table 1 here 
------------------------------------------- 
 
Meniere’s disease patients versus Controls 
Group differences are shown in Table 1.   More Meniere’s participants were taking medication 
(p<.001) versus controls, and by definition all Meniere’s participants reported hearing loss 
(p<.001).  Meniere’s participants reported significantly higher susceptibility to visual display 
dizziness VDD (p<.001), more frequent social life, family life, travel and work difficulties as 
individual questions and as a total SWID4 score (p<.001), more frequent headache (p<.001) and 
migraine (p<.001), and increased syncope (p<.001) compared to controls (see Figure 1). MSSQ 
scores were higher in Meniere’s patients than controls (p<.001) but only after the development 
of Meniere’s disease and not before disease onset (significant ANOVA interaction F= 78.5 df 
2,1930; p<0.001)) (Table 1, Figure 2) .  
Multivariate analyses (logistic) were performed in which the dependent variable was Meniere’s 
versus Controls, and predictor variables were age, gender, hearing, medication, VDD, SWID4, 
syncope, headache, migraine, MSA, MSB, MSC.  These analyses were also repeated replacing the 
MSSQ scores with a single derived score of rise in motion sickness susceptibility from childhood.  
Significant predictors of Meniere’s were higher VDD (p<.05), SWID4 (p<.001), syncope 
(marginal p=.058), higher MSC (p<.001) and lower MSB (p<.01). The latter MSB with MSC 
opposite predictor relationship was an artefact due to the relative rise in susceptibility after the 
onset of Meniere’s.  To clarify this, a derived rise in motion sickness susceptibility score 
(MSAC_dif) was calculated as the difference (PartC minus PartA) between Child Part A and Adult 
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Part C (employing a Part B with Part C difference would be tautological for the Controls since 
Part C for controls was cloned from Part B, see methods).  The results of this logistic regression 
were very similar to the previous one, except that a greater rise in motion sickness 
susceptibility (MSAC_dif) became the single motion sickness predictor for Meniere’s (p=.002).  
In these analyses none of the variables age, gender, hearing, medicines, headaches and migraine, 
were significant predictors.   Finally an exploratory factor analysis was performed to provide an 
overview of the relationships between all these variables (see Table 2).  This showed that age 
(younger), gender (female), headaches & migraine formed a second factor (17% variance) 
separate from the first factor (30% variance) composed of those variables more closely 
associated with Meniere’s.   
------------------------------------------- 
Figure 2 here 
------------------------------------------- 
In order to place the results of this study in a wider context, motion sickness susceptibility 
questionnaire (MSSQ) adult scores are shown for the current study compared with other 
patient groups from previous studies [1, 3, 4] after the onset of disease, in Figure 3.  The patient 
groups with corresponding ‘n’ in brackets were as follows: controls combined from this study 
and studies [3, 4] (n=525); bilateral vestibular loss (n=17); unilateral vestibular loss (n=45); 
vestibular neuritis (n=12); benign paroxysmal positional vertigo (n=28); vestibular migraine 
(n=26); clinical migraine patients attending migraine clinic (n=12); Meniere’s disease (n=751).  
It can be seen in Figure 3 that Meniere’s patients had elevated motion sickness susceptibility 
compared to controls (p<.001) but somewhat lower motion sickness susceptibility compared to 
vestibular migraine and clinical migraine patients. Vestibular migraine and clinical migraine 
patients have greatly elevated motion sickness susceptibility by a factor of 1.7 and 1.8 
respectively compared with controls, whereas Meniere’s disease leads to an increased 
susceptibility by a factor of 1.5 (see Figure 3).  
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Table 2 here 
------------------------------------------- 
Frequency of Vertigo attacks in Meniere’s patients 
The mean (SD) frequency of vertigo attacks in the last 1 month was 3.6 (6.6) attacks and in the 
last 6 months was 16.4 (39.9) attacks.   The wide variation of attack frequency prompted 
analysis of possible predictors or correlated variables.  Since the 1 and 6 month attack 
frequencies highly intercorrelated (r=.76 p<.0001), a single composite variable was constructed 
incorporating both 1 & 6 months frequencies by means of combining their z-scores, to give them 
equal weighting.  Having a single composite measure of frequency of attacks simplified analyses. 
In decreasing order of importance the following were associated with greater frequency of 
vertigo attacks: higher SWID4 (r=.25 p<.0001); higher VDD (r=.21 p<.0001); greater motion 
sickness susceptibility post MD onset (r=.19 p<.001); more migraine (r=.16 p<.001); syncope 
(r=.15 p<.001).  Other variables such as sex were not either not significantly associated with 
frequency of attacks, or for age the association was trivial (r=-.09 p<.05).  Multiple linear 
regression to predict frequency of attacks produced a significant (F=7.5 df 10,630 p<.0001) but 
weak predictive model (9.2% variance, adjusted Rsquare) with only SWID4 (p<.001), VDD 
(p<.01) and syncope (p<.05) as predictors, other predictors such as motion sickness 
susceptibility or migraine now failing significance in the face of the significant predictors in the 
model.  Finally exploratory factor analysis (Varimax rotated) was employed within the 
Meniere’s patients to provide an overview of the latent relationships between vertigo attack 
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frequency and other variables. Factor 1 (26% variance) loaded frequency of vertigo attacks, 
SWID4, VDD & MSS post disease.  Factor 2 (25% variance) loaded headaches, migraine, syncope 
& MSS post disease.  This suggested that MSS post disease had a complex relationship relating 
across the different latent dimensions of what might be termed (Factor 1) ‘Vertigo-Dizziness’ 
and (Factor 2) ‘Migraine-Syncope’.  
 
Unilateral versus Bilateral Meniere’s disease  
From the seven hundred and fifty-one Meniere’s participants, 480 were unilateral and 271 
bilateral. Results between unilateral Meniere’s and bilateral Meniere’s participants are shown in 
Table 3. Bilateral Meniere’s patients had longer disease duration (p<.001), were younger at 
disease onset (p=.002), experienced higher number of attacks of vertigo in the previous one 
month (p=.004), higher total SWID4 scores (p=.002), and higher motion sickness susceptibility 
after disease onset (MSC scores) (p<.001). Despite higher levels of disease activity (higher 
number of vertigo attacks) in bilateral MD participants, there was no significant difference in 
total migraine scores between unilateral and bilateral MD (p=.228).  
------------------------------------------- 




The aim of this experiment was to investigate motion sickness susceptibility in a large 
population of Meniere’s disease patients and controls using an online survey.  We also 
considered possible co-factors including migraine, syncope, visual display dizziness (VDD) and 
social life and work impact of dizziness (SWID4).  Patients with Meniere’s disease had elevated 
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motion sickness susceptibility compared to controls.  Higher motion sickness susceptibility 
occurred only after the onset of Meniere’s disease but not before nor in childhood, suggesting a 
causal effect related to the disease.  Motion sickness susceptibility scores after diagnosis (MSC 
scores) were 1.5 times higher in Meniere’s disease patients compared with controls.  This is 
similar to that reported in a telephone survey by Sharon & Hullar [6]. Compared with controls, 
Meniere’s disease patients also suffered from more headaches and migraine, increased VDD, 
higher SWID4 scores, and increased syncope. Further analyses were performed exploring the 
relationship between Meniere’s and motion sickness susceptibility and the possible co-factors.  
These are discussed below.  
Meniere’s disease (MD) is a very disabling condition, which has a huge impact on patients’ 
physical and mental health. Alongside episodic attacks of vertigo, Meniere’s disease is 
associated with fluctuating auditory and vestibular signs e.g., hearing loss, tinnitus, aural 
fullness, dizziness and headache and migraine [10,14]. Regarding the latter, recent studies have 
highlighted the greater prevalence of migraine in Meniere’s disease patients compared to other 
balance disorders (45% vs 9%) [15]. In the present survey we observed that the Meniere's 
disease patients scored higher than controls on the migraine scale. It is well known that 
migraine elevates motion sickness susceptibility [2,3] and in our study bivariate analysis 
showed an association between migraine and Meniere’s disease.  However, we found that 
migraine was not as strongly related to Meniere’s disease as other factors in the face of 
multivariate analyses.  This was shown both by logistic regression and by factor analysis (Table 
2).  Rather than migraine, Meniere’s disease was instead more strongly associated with other 
factors; hearing, medication, visual display dizziness, SWID4, syncope and motion sickness 
susceptibility. An analogous finding by Bosser and colleagues [11], demonstrated that any 
relationship between motion sickness susceptibility and migraine in the general population was 
attenuated after multivariate correction for other factors. More important predictors such as 
autonomic reactivity replaced migraine.  Thus, migraine is unlikely to explain the higher motion 
sickness susceptibility in Meniere’s disease compared to controls.  Also consistent with this 
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view is that Meniere’s disease participants do not have as high motion sickness susceptibility as 
clinical migraine patients themselves (see Figure 3).  
A more likely explanation for the elevated motion sickness susceptibility scores in Meniere’s 
disease is increased sensory conflict, since sensory conflict is the underlying mechanism for 
motion sickness [1]. Visual and vestibular sensory conflicts occur in Meniere’s disease during 
vertiginous symptoms and also during motion sickness [16,17]. Prolonged and recurrent 
episodes of vertigo in Meniere’s disease cause a progressive loss of accurate vestibular 
perceptions and unstable vestibular gain levels [18]. As such, the sensory conflict during 
provocative motion stimuli is higher in Meniere’s disease compared to healthy controls. This 
shared aetiology between Meniere’s disease and motion sickness may thus exaggerate sensory 
conflict during provocative motion stimuli.  
Bilateral Meniere’s disease participants had higher levels of disease activity than unilateral, as 
indicated by increased numbers of vertigo attacks (Table 3), although others have found no 
difference [19,20]. We found that bilateral sufferers had higher motion sickness susceptibility 
than unilateral sufferers (MSC scores).  To our knowledge this is the first time that this 
observation has been reported in the literature.  A higher level of disease activity in bilateral 
sufferers is not surprising as vertigo episodes can begin from either ear which increases the 
chances of attacks. Furthermore, the bilateral condition decreases the interval between attacks. 
The continual vestibular changes could therefore relate to higher motion sickness susceptibility, 
as suggested above as a probable mechanism. 
Although not a primary aim of this study, the large variation in frequency of vertigo attacks 
between individuals suffering Meniere’s disease prompted an attempt to find correlates or 
predictors.  This was only partially successful.  Bivariate correlations showed that increased 
frequency of vertigo attacks were associated with significantly higher SWID4 and VDD, greater 
motion sickness susceptibility post disease, more migraine, more syncope, but other variables 
such as sex and age showed non significant or trivial relationships. Multivariate analyses within 
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Meniere’s disease patients revealed a straightforward picture at first sight, in which a latent 
‘vertigo-dizziness’ factor emerged independently from a second factor which might be termed 
‘migraine-syncope’.  However, the relationship of elevated motion sickness susceptibility (post 
disease onset) was more complex, spreading across both these factors, but more strongly with 
‘vertigo-dizziness’.   
The emergence of a vertigo-dizziness factor in multivariate analysis within the Meniere’s 
patients, pulls together vertigo attacks, the SWID4 and VDD, with motion sickness susceptibility 
(MSC scores). As vertigo attacks in Meniere’s disease are sporadic and episodic, the relationship 
between the number of vertigo attacks and increased difficulty in social, travel, family, and work 
life is unsurprising and presumably causal. The vertigo-dizziness factor also suggests a possible 
causal relationship between vertigo attacks and difficulty using visual displays, showing that an 
everyday task such as using a computer, smart phone, or tablet is sufficiently provocative to 
induce unease in Meniere’s disease.  
A possible limitation of this work was the self-report of a doctor’s diagnosis of Meniere’s 
disease. Indeed there can be confusion among some physicians as to diagnosis of Meniere’s vs 
migraine or other vestibular related conditions. Although Meniere’s disease participants 
without hearing loss were removed, it is possible that our cohort included a residual number of 
patients with other vertiginous conditions or had sub-clinical/unrelated hearing loss. However, 
we asked Meniere’s disease participants to score the number of vertigo attacks they 
experienced in the 6 months and 1 month prior to the online survey. Whilst it could be argued 
that patients might not recall the number of attacks accurately over a 6 month period, vertigo attacks 
over 1 month paralleled the 6 month number of vertigo attacks (r=.76 p<.0001), suggesting accurate 
recollection. Also, these numbers were almost identical to frequency of vertigo we recently 
monitored in Meniere’s disease patients with diagnostic confirmation by an experienced neuro-
otological team.  In addition this number of reported vertigo attacks are concordant with those 
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reported from a large scale Meniere’s disease intervention trial in another country [21].  This 
shows external consistency with the results of this survey. 
In conclusion, motion sickness susceptibility, visual display dizziness, social life & work impact 
of dizziness, migraine, and syncope were elevated in Meniere’s disease versus Controls. 
Meniere’s disease itself increased Motion Sickness Susceptibility even after accounting for any 
effects of any associated migraine.  
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Figure 1: Headache, Migraine and SWID4 mean scores in Meniere’s disease (MD) and Controls. 
Meniere’s patients rated their Headache, Migraine and SWID4 scores significantly higher than 






Figure 2:  Motion Sickness Susceptibility Questionnaire mean scores in Meniere’s (MD) and 
Control (Con) participants at different stages in life. From left to right: In Childhood; as an adult 
before MD or the control participant’s adult score (Con); and during MD or the control 




Figure 3.  Motion sickness susceptibility questionnaire (MSSQ) adult scores are shown for this 
study and compared with other patient groups after onset of disease.  MSSQ Percentile scores 
are used to enable comparison with previous data.  Significances are comparisons of each 
patient group with age equivalent healthy controls. Both single standard deviation (SD) bars 
(grey) and 95%CI bars (black) are shown in the figure. The 95%CIs are smaller for controls and 
Meniere’s disease as a consequence of larger numbers. BVL: bilateral vestibular loss; UVL: 
unilateral vestibular loss; BPPV: benign paroxysmal positional vertigo.  See text for details. 

















Hearing loss 100% 18% <.001 -- 
Medication use 73.1% 47.3% <.001 -- 
Susceptibility to visual display dizziness 51.0%  14.6% <.001 -- 
SWID “Social life” restricted/difficult 90.3% 18.0% <.001 -- 
SWID “Family life” restricted/difficult 76.1% 17.7% <.001 -- 
SWID “Travel” restricted/difficult 72.4% 20.9% <.001 -- 
SWID “Work” restricted/difficult 72.0% 13.5% <.001 -- 
SWID4 total score 3.1 + 1.2 .7 + 1.3 <.001 2.3 to 2.6 
Frequency of headaches (range) 2.1 + .8 1.8 + .8 <.001 .23 to .43 
Migraine total score (0-6)  3.3 + 1.9 2.6 + 2.0 <.001 .46 to .94 
Experience of Syncope 39.2% 16.4% <.001 -- 
MSA score (Child Mot Sick Suscep)  12.0 + 8.9 11.5 + 
8.5 
.394 -.63 to 1.6 
MSB score (Adult Mot Sick Suscep) 11.6 + 8.5 10.6 + 
8.0 
.088 -.14 to 2.0 
MSC score (Post Disease Mot Sick Suscep) 16.5 + 8.2 10.6 + 
8.0 
<.001 4.8 to 6.9 
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Table Notes: For illustrative purposes loadings <.3 are not shown; Varimax rotation converged in 
three rotations.  
  
Factor Analysis Factor 
1 2 
Group (Meniere’s/Controls) -.89  
Age  -.57 
Gender  .44 
Hearing Loss .88  
Medication use .41  
Visual Display Dizziness (VDD) .59  
Soc. Work Impact Dizziness (SWID4) .84  
Syncope .33  
Headaches  .73 
Migraines  .73 
Motion Sickness Susceptibility .41  
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Table 3: Unilateral Meniere’s disease versus Bilateral Meniere’s disease, summary of responses 
















Age (years) 49.6 + 10.9 50.0 + 11.6 .623 -2.1 to 1.3 
Gender (F:M) 403:77 226:45 .837 -- 
Disease duration (years) 9.8 + 9.6 13.2 + 11.4 <.001 -4.9 to -1.9 
Age of disease onset (years) 39.8 + 12.4 36.8 + 12.6 .002 1.1 to 4.9 
Vertigo attacks in previous one month 3.1 + 5.6 4.5 + 8.1 .004 -2.4 to .47 
Vertigo attacks in previous six months 13.7 + 30.4 21.1 + 52.5 .014* -13 to -1.5 
Migraine total score (0-6) 3.2 + 1.9 3.4 + 1.8 .228 -.46 to .11 
SWID4 total score 3.0 + 1.2 3.3 + 1.0 .002 -.42 to -.09 
MSA score 11.7 + 8.7 12.6 + 9.2 .171 -2.4 to .43 
MSB score 10.9 + 8.1 12.8 + 9.0 .007* -3.2 to -.52 
MSC score 15.5 + 8.2 18.2 + 7.8 <.001 -4.0 to -1.4 
 




Meniere’s Disease Survey 
 
Please note that:  
Participation is entirely voluntary and you have the right to stop at any time without reason. 
All responses are confidential, no individuals will be identifiable from the report or any 
publications arising from it. All personal information you provide will be kept securely, and 
you have the right to ask for it to be destroyed. Only persons above 18 years of age should 
complete this survey.  
 
I have read the above information and agree to participate (check on box)    No  Yes 
 
Instructions: please write in your answer or check your choice as appropriate. 
 
1. Please state your Age   ............. Years 
2. Please indicate your Gender (Sex)  Male   Female 
3. What is your Meniere’s disease diagnosis?    Unilateral   Bilateral 
4. Do you have hearing loss from the disease?  No  Yes 
5. How long have you suffered from Meniere’s ?    ………..  Years 
6. How many Vertigo Attacks (over 20 mins) have you had during the last month?     …….. 
7. How many Vertigo Attacks (over 20 mins) have you had in the last six months?     ……… 
8. Are you taking medication for Meniere’s?  No Yes  
9. If ‘Yes’, please state which medication(s)  …………………………….  
10. Has Meniere’s disease impeded your use of visual interfaces (e.g., smart phones, 
computers, tablets)?   No     Yes  
11. Have balance/ dizziness problems caused difficulties in your social life (e.g. restrictions 
on going out, planning holidays, etc) ?  No  Yes 
12. Have balance/ dizziness problems caused difficulties in your family life?  No  Yes
  
13. Have balance/ dizziness problems restricted your ability to travel? (e.g. cannot ride bike, 
travel by car, plane)   No Yes  
14. Have balance/dizziness problems restricted or prevented you from working?   No     
Yes 
 23 
15. Are you susceptible to vasovagal syncope?  No Yes     
Vasovagal syncope or presyncope is a medical condition in which you suddenly feel weak 
and faint, or actually faint and lose consciousness.  It is always provoked by a particular 
circumstance such as stress, strong emotion, pain, prolonged upright position, hot 
environment or sight of blood. Other symptoms may include headache, nausea or vomiting, 
visual troubles, sensation of heat, cold sweating, facial pallor, lowered blood pressure and 
heart rate. 
 
16. If ‘Yes’ to vasovagal syncope, please state facilitating factors, circumstances and 
symptoms:  ………………………………………………………………………………… 
17.  Do you ever experienced loss of consciousness during vasovagal episodes?     No      
Yes 
18. Do you have headaches ?     never      rarely     sometimes     
often  
19. Are they throbbing ?      No Yes   
20. Are they on just one side of your head ?    No Yes 
21. During the headache are you sensitive to light?     No    Yes    
22. During the headache are you sensitive to sound?    No    Yes   
23. Does the headache make you feel nauseated?    No   Yes 
24. Has a doctor called your headaches migraine ?   No Yes 
 
Motion Sickness Susceptibility 
This questionnaire is designed to find out how susceptible to motion sickness you are, and what sorts of 
motion are most effective in causing that sickness.  Sickness here means feeling queasy or nauseated or 
actually vomiting.   
 
Your CHILDHOOD Experience (before age12 years), for each of the following types of transport or 
entertainment please indicate as a CHILD (before age 12), how often you Felt Sick or Nauseated (tick 
boxes): 














Cars       
Buses or Coaches      
Trains      
Aircraft      
Small Boats      
Ships, e.g. Channel Ferries      
Swings in playgrounds      
Roundabouts in playgrounds      





Before the onset of your Meniere’s Disease: this concerns your ADULT experience 10 YEARS previously. 
For each of the following types of transport or entertainment please indicate how often you Felt Sick or 














Cars       
Buses or Coaches      
Trains      
Aircraft      
Small Boats      
Ships, e.g. Channel Ferries      
Swings in playgrounds      
Roundabouts in playgrounds      
Big Dippers, Funfair Rides      
      t          0      1             2            3 
 
After the onset of your Meniere’s Disease your ADULT experience over the last 10 YEARS 
approximately, for each of the following types of transport or entertainment please indicate how often 














Cars       
Buses or Coaches      
Trains      
Aircraft      
Small Boats      
Ships, e.g. Channel Ferries      
Swings in playgrounds      
Roundabouts in playgrounds      
Big Dippers, Funfair Rides      
    t  0  1             2                     3 
 
Thank you for completing this survey 
 
 
